Unbiased Analysis of Today's Healthcare Issues
That is the question that the Outcome Measures in Rheumatology (OMERACT) Working Group attempted to answer. Specifically, the working group aimed to determine the core set of outcome domains for measuring the effectiveness of shared decision-making (SDM) interventions within clinical trials used to treat rheumatic diseases. These diseases included osteoarthritis (OA), rheumatoid arthritis (RA), and psoriatic…
The answer seems to be just find the “best” treatment. In theory this sounds easy, but in practice it is difficult. What does best mean? What if one treatment has better outcomes on average but is riskier? What if one treatment is more effective than another but requires injections rather than pills? What if patients have…
In one of my recent publications, I show that patient and physician risk preferences differ. Patients are willing to take take treatments with more both upside and downside risk, whereas physician prescribe treatments large based on which one provides the most efficacy to the average patient. One question that remains is how do patients and physician preferences over treatments…